People

Dutch biotech company Mucosis B.V. has promoted Thomas Johnston, the company's Chief Business Officer since May 2011, as CEO, replacing Govert Schouten. Prior to joining Mucosis, which is developing intranasal vaccines based on its Mimopath platform, Johnston was VP of Strategy at Novavax. Mucosis Chairman of the Board John Lambert said, "Tom has more than 15 years … [Read more...] about Mucosis appoints Thomas Johnston as CEO

Arikace developer Insmed Incorporated has appointed Will Lewis, co-founder of Aegerion Pharmaceuticals, to succeed Tim Whitten as President and Chief Executive Officer. According to the company, Whitten has resigned from the board of directors as well, and Lewis will join the board. Donald J. Hayden, Jr., who was appointed Executive Chairman earlier this year, … [Read more...] about New CEO for Insmed

Civitas Therapeutics has appointed Bryan Stuart as Chief Business Officer. Civitas, which was spun off from Alkermes, is developing carrier-free inhaled drugs based on its ARCUS particle engineering platform and inhaler. The company's lead candidate is CVT-301 inhaled L-dopa for the treatment of Parkinson's disease. Civitas CEO Glenn Batchelder said, “We are very … [Read more...] about Civitas Therapeutics appoints Bryan Stuart as Chief Business Officer

Pulmatrix has announced that Robert Clarke will succeed Robert Connelly as the company's Chief Executive Officer. Clarke has been with the company, which is developing inhaled drugs based on its proprietary iSPERSE (inhaled small particles easily respirable and emitted) platform, since 2004 as VP of Research & Development and as Chief Scientific Officer. Clarke … [Read more...] about Pulmatrix appoints Robert Clarke as CEO

Hovione has named Mike Ironside as General Manager of its Technology Transfer Center (TTC), which is located in New Jersey. Ironside was most recently with Anacor Pharmaceuticals and has previously worked for GSK and AMRI. Hovione VP of Corporate R&D Thomas Eisele said, "This is a key appointment at an important time for Hovione. We are certain that Dr. Ironside's … [Read more...] about Hovione appoints new General Manager of its Technology Transfer Center

Particle manufacturing specialist Liquidia Technologies has named Benjamin Yerxa, most recently at Clearside Biomedical, as its new Chief Scientific Officer. Yerxa will oversee R&D, "including a focus on scientific collaborations," for the company. Liquidia's PRINT nanofabrication technology can produce particles of specified sizes and shapes for inhalation powders … [Read more...] about Liquidia hires Benjamin Yerxa as Chief Scientific Officer

Hovione has announced the appointment of Conrad Winters as Director, Drug Product Development. Winters most recently was Senior Director of the Compound Properties Group at Xenon Pharmaceuticals and previously held positions with Merck. Hovione VP of Corporate Research & Development Thomas Eisele commented, "We are very pleased to welcome Dr. Winters to Hovione. … [Read more...] about Hovione hires Conrad Winters as Director of Drug Product Development

Inhaled drug company Alexza Pharmaceuticals has announced the promotions of four executives. The company has promoted James V. Cassella to Executive VP, Research and Development and Chief Scientific Officer; Darl Moreland to Senior VP, Quality; Mark K. Oki to Senior VP, Finance and Chief Financial Officer; and Edwin S. Kamemoto to VP, Regulatory Affairs. … [Read more...] about Promotions at Alexza

Indian pharmaceutical company Cipla has hired former Teva vice-president Frank Pieters as Head of European Business and Head of Global Respiratory Business. Pieters was most recently Senior VP for the Region of Southern Europe at Teva. Cipla manufactures a wide range of inhaled medications. A recent article in the Business Standard quotes Cipla CFO S Radhakrishnan … [Read more...] about Cipla hires Frank Pieters to head respiratory business

Insmed Incorporated, which is developing Arikace liposomal amikacin for inhalation, has appointed Donald J. Hayden, Jr. as Executive Chairman of its Board of Directors, effective immediately. He has been serving as Chairman of the board of directors since the end of 2010 when Insmed merged with Transave, and he will continue to focus on the development of Arikace … [Read more...] about Insmed appoints Donald J. Hayden, Jr. as Executive Chairman of the Board of Directors